Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TORSEMIDE
- Immediate Release Versus Extended Release Torsemide After Salty Meal
- Torsemide Comparison With Furosemide for Management of Patients With Stable Heart Failure
- Dapagliflozin in Diabetic Patients (Type 2) With Decompensated Heart Failure
- Comparison of Once Daily 40 mg Torsemide With Twice-daily 40 mg Furosemide
- TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure
- A Food Effect Study of 60mg ER Torsemide
- Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects
- Weight-Based Torsemide Dosing in Subjects With Heart Failure
- High-dose Aldosterone Antagonist for Acute Decompensated Heart Failure
- ToRsemide for pOstpartum HYpertension
- Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders
- The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics
- Open Label Study for the Functional Characterization of Drug Metabolism and Transport
- A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011)
- Assessment of Coronary Flow Reserve in Heart Failure Patients After Ultrafiltration Versus Diuretics
- Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?
- Bioavailability Study of Torsemide Tablets Under Fed Conditions
- Bioavailability Study of Torsemide Tablets Under Fasting Conditions
- Bioequivalency Study of Torsemide Tablets Under Fed Conditions
- Bioequivalency Study of Torsemide Tablets Under Fasting Conditions
- Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension.
Clinical trials list
click for details